Phase 1 dose-escalation study of ACT001 in patients with recurrent glioblastoma and other advanced solid tumors.

Authors

null

Jason D. Lickliter

Nucleus Network Limited, Melbourne, Australia

Jason D. Lickliter , Ross Jennens , Charlotte Rose Lemech , Ganessan Kichenadasse , Dongpo Cai , Steven Yung-Chang Su

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2021 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Central Nervous System Tumors

Track

Central Nervous System Tumors

Sub Track

Primary CNS Tumors–Glioma

Clinical Trial Registration Number

ACTRN12616000228482

Citation

J Clin Oncol 39, 2021 (suppl 15; abstr 2037)

DOI

10.1200/JCO.2021.39.15_suppl.2037

Abstract #

2037

Poster Bd #

Online Only

Abstract Disclosures

Similar Posters

First Author: Yehui Shi

First Author: Jordi Rodon Ahnert

First Author: Sant P. Chawla

First Author: Martin Kelly Nicholas